Remove conference hopa-annual-conference
article thumbnail

Novel Agents Generate Excitement for Hematologic Malignancies

Drug Topics

During a session at the 2023 HOPA Annual Conference, Rebecca Champion, PharmD, BCOP, highlighted new therapies in the market for hematologic malignancies with a focus on bispecific antibodies and chimeric antigen receptor T-cell therapies.

185
185
article thumbnail

Toxicity Management Crucial When Combining Novel Agents

Drug Topics

Off-label drug combinations are increasingly being used in cancer treatments, but there is the potential for overlapping or additive toxicities, explained a speaker at the 2023 HOPA Annual Conference.

article thumbnail

Encourage Patients to Call Between Visits for Better Toxicity Management During Treatment

Pharmacy Times

It would also be beneficial to include a patient’s entire healthcare team in this management strategy, said an expert at the Hematology/Oncology Pharmacy Association (HOPA) Annual Conference 2023 in Phoenix, Arizona.

65